Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

ConclusionsttIL-12 when combined with surgery led to conversion to the IFN γHiCD8HiFOXP3LowCD33Low immune profile, eliminated relapse and metastasis, and prolonged overall survival.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research